Literature DB >> 9243742

Predictors of human immunodeficiency virus counseling and testing among sexually transmitted disease clinic patients.

S K Schwarcz1, C Spitters, M M Ginsberg, L Anderson, T Kellogg, M H Katz.   

Abstract

OBJECTIVES: To determine the predictors of prior or current, and repeat human immunodeficiency virus (HIV) testing. STUDY
DESIGN: Cross-sectional survey.
METHODS: Sexually transmitted disease (STD) clinic patients who participated in a blinded HIV seroprevalence survey completed a voluntary questionnaire regarding their reasons for accepting or declining HIV testing.
RESULTS: Eighty-seven percent of participants reported a previous HIV test or were HIV testing the day they completed the questionnaire. African Americans were less likely to have been HIV tested (adjusted odds ratio 0.3, 95% confidence limits, 0.1, 0.8). The most common reasons for testing were to be reassured and to receive medical care if infected. The most common reason for not testing was that nontesters did not think that they were infected. Repeated testing was reported by 51% of the participants and was more frequent among patients who were older or members of high-risk groups (P < 0.05). Patients tested repeatedly to confirm a prior HIV test result or because of continued risky behavior.
CONCLUSIONS: Testing for HIV is frequent among STD clinic patients but less so among African Americans. Receipt of medical care appears to be an important motivation for HIV testing, whereas lack of perceived risk may discourage testing. Continued high-risk behavior contributes to repeat HIV testing.

Entities:  

Mesh:

Year:  1997        PMID: 9243742     DOI: 10.1097/00007435-199707000-00007

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  8 in total

1.  Delayed access to HIV diagnosis and care: Special concerns for the Southern United States.

Authors:  Christopher S Krawczyk; Ellen Funkhouser; J Michael Kilby; Sten H Vermund
Journal:  AIDS Care       Date:  2006

2.  Frequent HIV testing among participants of a routine HIV testing program.

Authors:  Hazel Williams-Roberts; Yuchiao Chang; Elena Losina; Kenneth A Freedberg; Rochelle P Walensky
Journal:  Virulence       Date:  2010 Mar-Apr       Impact factor: 5.882

3.  Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic.

Authors:  Christopher S Krawczyk; Ellen Funkhouser; J Michael Kilby; Richard A Kaslow; Amita K Bey; Sten H Vermund
Journal:  South Med J       Date:  2006-05       Impact factor: 0.954

4.  Perceived everyday racism, residential segregation, and HIV testing among patients at a sexually transmitted disease clinic.

Authors:  Chandra L Ford; Mark Daniel; Jo Anne L Earp; Jay S Kaufman; Carol E Golin; William C Miller
Journal:  Am J Public Health       Date:  2009-02-12       Impact factor: 9.308

5.  Improving HIV rapid testing rates among STD clinic patients: a randomized controlled trial.

Authors:  Michael P Carey; Patricia Coury-Doniger; Theresa E Senn; Peter A Vanable; Marguerite A Urban
Journal:  Health Psychol       Date:  2008-11       Impact factor: 4.267

6.  Willingness and Barriers to Voluntary Counselling and Testing Among Self-Perceived Healthy Adults in Tanzania.

Authors:  Michael A Munga; Janesta A Urassa; William J Kisoka; Prince P Mutalemwa
Journal:  East Afr Health Res J       Date:  2019-07-30

7.  Determinants of late disease-stage presentation at diagnosis of HIV infection in Venezuela: a case-case comparison.

Authors:  Maeva A Bonjour; Morelba Montagne; Martha Zambrano; Gloria Molina; Catherine Lippuner; Francis G Wadskier; Milvida Castrillo; Renzo N Incani; Adriana Tami
Journal:  AIDS Res Ther       Date:  2008-04-16       Impact factor: 2.250

8.  HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014.

Authors:  Ruth Simmons; Ruslan Malyuta; Nelli Chentsova; Antonia Medoeva; Yuri Kruglov; Alexander Yurchenko; Andrew Copas; Kholoud Porter
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.